VOSSIUS is a partnership of patent attorneys and attorneys-at-law with offices in Munich, Düsseldorf, Berlin and Basel. Established in 1961, it is today one of Europe’s leading IP firms with clients from all over the world.
The firm focuses on high-end advice for innovative companies concerning all questions associated with the protection and the enforcement of intellectual property rights. The firm’s areas of expertise comprise all IP fields (patents, trademarks, copyrights, design rights, SPCs etc.), as well as licensing, competition law, pharmaceutical law (e.g. approvals), media law, IT law, data protection and food law. Due to a global network of colleagues abroad, particularly in the USA, Asia and Europe, VOSSIUS advises and attends also for international protective rights.
As a full-service intellectual property law firm, VOSSIUS offers their clients the technological and scientific know-how of experienced patent attorneys in combination with the knowledge and competence of highly specialized attorneys-at-law. Based on decades of experience, the firm can provide a comprehensive range of services. This translates into the best possible client counseling and the greatest possible protection of intellectual property assets during all phases of legal disputes and litigation.
The areas of expertise of VOSSIUS extend to the entire range of sciences and technology: the firm represents inventions from all fields of chemistry and pharmacology, biology and biotechnology, physics, electrical engineering and information technology, as well as mechanical engineering.
For Asian clients as well as for clients doing business in Asia, we have established an integrated Asia Desk consisting of attorneys and consultants from Japan, China, Korea and Taiwan, some of whom are not only qualified in their respective country but also as European patent attorneys or lawyers.
Legal Notice: www.vossius.eu/en/imprint
Data Protection Information: www.vossius.eu/en/data-protection
🧬 Join VOSSIUS and BioM Biotech Cluster Development GmbH for their Biotech & IP Seminar for Founders and Startups taking place in Munich on May 22nd and May 23rd, 2025!
Explore the critical intersection of innovation, intellectual property, and business strategy on topics including:
- Basics of patentability of biotech inventions
- Financing of startups
- Freedom-to-operate issues
- International and domestic licensing
- Issues with the Employee Inventions Act
- AI in inventions and patent law
- Strategic filings
- Copyright issues
- A U.S. perspective
- SPCs and regulatory affairs
Register today and take a first step toward taking your ideas further.
For more details and registration, please visit our website:
https://lnkd.in/dNiWUQH2#Biotech#LifeSciences#Seminar#Munich
Dieser Inhalt ist hier nicht verfügbar.
Mit der LinkedIn App können Sie auf diese und weitere Inhalte zugreifen.
VOSSIUS Partner Dr. Kai Rueting, LL.M. will co-host C5’s complimentary pre-conference webinar “Preliminary Forum Selection: Insights & Strategies” (16 April 2025, 1 – 2 p.m. CET) together with Liz Cohen (Partner, Bristows LLP) and Gertjan Kuipers (Partner, Hogan Lovells).
This webinar will explore key strategies and insights for forum selection in biopharma patent disputes, discussing UPC’s Local Divisions application of EPO and national law, analysing impactful cases as well as first decisions and more.
➡️ Follow the link for more information and registration: https://lnkd.in/d7w4nVin#Biopharma#LifeSciences#Litigation#UPC
We are delighted to share that VOSSIUS client Araris Biotech AG has officially been acquired by Taiho Pharmaceutical Co., Ltd. for up to USD 1.14 billion. VOSSIUS has been advising Araris for many years, managing their entire IP portfolio both operationally and strategically. Over several months, a VOSSIUS team led by Dr. Philipp Marchand and Dr. sc. ETH Tilmann Kuenzl supported Araris in the IP due diligence process and will continue to work closely with the company.
Congratulations to the entire team at Araris on this outstanding achievement!
Further information: https://lnkd.in/dWkE9hGs#Biotech#IntellectualProperty#ADCs#Acquisition
𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗦𝘁𝗮𝗿𝘁𝘂𝗽𝘀 & 𝗙𝗼𝘂𝗻𝗱𝗲𝗿𝘀 - 𝗗𝗼𝗻'𝘁 𝗺𝗶𝘀𝘀 𝘁𝗵𝗲 ⚖️ 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 & 𝗜𝗣 𝗦𝗲𝗺𝗶𝗻𝗮𝗿 2025 ⚖️ 𝗶𝗻 𝗠𝘂𝗻𝗶𝗰𝗵!
We are pleased to invite you to this exclusive event designed to help #biotech#entrepreneurs navigate the critical intersection of #innovation, intellectual property and business strategy, co-organized by BioM Biotech Cluster Development GmbH and VOSSIUS! The event will provide valuable insight into the challenges and opportunities facing today's 💡 biotech innovators.
𝗗𝗮𝘁𝗲: Thursday, May 22nd and Friday, May 23rd 2025
𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: #BioM, Am Klopferspitz 19a, Martinsried/#Munich
𝗠𝗼𝗿𝗲 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 & 𝗿𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻: https://lnkd.in/eeMdRaFR
𝗧𝗼𝗽𝗶𝗰𝘀 𝘄𝗶𝗹𝗹 𝗶𝗻𝗰𝗹𝘂𝗱𝗲:
💠Basics of patentability of biotech inventions
💠#Financing startups
💠International and domestic #licensing
💠Issues with the Employee Inventions Act
💠AI in inventions and #patentlaw
💠Strategic filings
💠#Copyright issues
Our 🧑⚖️🧑⚖️ expert speakers, including patent attorneys and attorneys-at-law from #VOSSIUS and distinguished guests from the biotech, patent law and startup funding communities, will provide 🔎 key insights 🔎 into the protection and commercialization of 💡 #biotechinnovations.
𝗪𝗲 𝗮𝗿𝗲 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝗳𝗼𝗿𝘄𝗮𝗿𝗱 𝘁𝗼 𝘄𝗲𝗹𝗰𝗼𝗺𝗶𝗻𝗴 𝘆𝗼𝘂!
#IP#IntellectualProperty#businessstrategy#biotechnology#healthtech#medtech#startup#founder#Seminar#Munich
🧬 Join VOSSIUS and BioM Biotech Cluster Development GmbH for their Biotech & IP Seminar for Founders and Startups taking place in Munich on May 22nd and May 23rd, 2025!
Explore the critical intersection of innovation, intellectual property, and business strategy on topics including:
▪️ Basics of patentability of biotech inventions
▪️ Financing of startups
▪️ Freedom-to-operate issues
▪️ International and domestic licensing
▪️ Issues with the Employee Inventions Act
▪️ AI in inventions and patent law
▪️ Strategic filings
▪️ Copyright issues
▪️ A U.S. perspective
▪️ SPCs and regulatory affairs
A detailed programme will soon be available.
Register today and take a first step toward taking your ideas further.
For more details and registration, please visit our website:
https://lnkd.in/dNiWUQH2#Biotech#LifeSciences#Seminar#Munich
This post is a celebration of the VOSSIUS women.
Nothing is more important for our female professionals and for us as an employer than interdepartmental team spirit, the creation of attractive working conditions for women at VOSSIUS and the improvement of career opportunities. This is why we promote and encourage informal dialogue as well as professional exchange. For this reason, we organise regular get-togethers during lunch breaks or after work in addition to business events. We want to encourage our female attorneys to help and support each other and to initiate joint projects and activities. It is therefore important to us to make the working conditions for women in our firm more attractive and to improve their career opportunities.
#WomenPower#InternationalWomensDay#Weltfrauentag#Diversity#Equality#WomensIP
VOSSIUS Partner and Litigator Philipp Widera will be attending the 2025 Sedona Conference on Global Intellectual Property Litigation which takes place in The Hague from March 24th to March 25th, 2025.
Together with Hon. Colm Connolly, Rachel Fetches, Adam Gill, and Azra Hadzimehmedovic, Mr. Widera will be a panelist on the topic of “Litigation Funding in Intellectual Property Cases”.
For more information about the conference, please visit: https://lnkd.in/e7vwzVyG#Conference#IP#Litigation
Join our partners Dr. Jürgen Meier and Dr. Andreas Kramer at the 2025 AIPPI MidTerm Meeting in Zagreb - a great occasion to meet friends and colleagues and to exchange ideas and insights within the international AIPPI community.
On Thursday, Dr. Kramer participates in the panel "Wind of Change in the SEP Landscape?" discussing latest developments in SEP / FRAND litigation.
We are looking forward meeting you in Croatia's capital city!
For more details: https://lnkd.in/gpWvHE4i#AIPPI#IntellectualProperty#SEP#FRAND#Litigation#Patents
🌟 VOSSIUS is shortlisted for seven awards at the Managing IP EMEA 2025 Awards.
Germany:
- Patent Disputes (Patent & Trademark Attorney Firms)
- Patent Prosecution
- Trademark (Patent & Trademark Attorney Firms)
- UPC Firm of the Year (Patent & Trademark Attorney Firms)
- Dr. Andreas Kramer - Practitioner of the Year (Patent & Trademark Attorney Firms)
Europe:
- EPO Proceedings Firm of the Year
- Patent Disputes (Patent & Trademark Attorney Firms)
Congratulations to our team at VOSSIUS and to Dr. Andreas Kramer for his nomination as Practitioner of the Year.
For more details, please visit our website:
https://lnkd.in/dF3AvTBN
We are keeping our fingers crossed.
#ManagingIP#EMEA#Patents#Trademarks#UPC#EPO
💡 Recent Decisions of the EPO Boards of Appeal in Biotechnology and Biopharmaceuticals
Join VOSSIUS Partners Dr. Hans-Rainer Jaenichen, Dr. Jürgen Meier and Dr. Andreas Heiseke for an insightful FORUM Institut online course presenting the most important decisions of the Boards of Appeal in the field of biopharmaceuticals and biotechnology. Learn more about the consequences of these decisions and changes on patent practice.
Date: Thursday, July 3rd, 2025
Time: 09:00-17:00 CET
Venue: Online
For more details and registration, please use the following link:
https://lnkd.in/ddrwsHVN#Biotechnology#Biopharmaceuticals#Webinar#EPO#Patents
